These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 10332805

  • 1. Effects of antihistamines on fenfluramine-induced depletion of indoles in the brain of rats.
    Yeh SY.
    Synapse; 1999 Jun 15; 32(4):301-11. PubMed ID: 10332805
    [Abstract] [Full Text] [Related]

  • 2. Effects of antihistamines on 3, 4-methylenedioxymethamphetamine-induced depletion of serotonin in rats.
    Yeh SY, Dersch C, Rothman R, Cadet JL.
    Synapse; 1999 Sep 01; 33(3):207-17. PubMed ID: 10420168
    [Abstract] [Full Text] [Related]

  • 3. Neurotoxic effects of +/-fenfluramine and phenteramine, alone and in combination, on monoamine neurons in the mouse brain.
    McCann UD, Yuan J, Ricaurte GA.
    Synapse; 1998 Nov 01; 30(3):239-46. PubMed ID: 9776127
    [Abstract] [Full Text] [Related]

  • 4. Fenfluramine and norfenfluramine levels in brain microdialysate, brain tissue and plasma of rats administered doses of d-fenfluramine known to deplete 5-hydroxytryptamine levels in brain.
    Clausing P, Newport GD, Bowyer JF.
    J Pharmacol Exp Ther; 1998 Feb 01; 284(2):618-24. PubMed ID: 9454806
    [Abstract] [Full Text] [Related]

  • 5. In vivo correlates of central serotonin function after high-dose fenfluramine administration.
    Baumann MH, Ayestas MA, Rothman RB.
    Ann N Y Acad Sci; 1998 May 30; 844():138-52. PubMed ID: 9668672
    [Abstract] [Full Text] [Related]

  • 6. N-tert-butyl-alpha-phenylnitrone protects against 3,4-methylenedioxymethamphetamine-induced depletion of serotonin in rats.
    Yeh SY.
    Synapse; 1999 Mar 01; 31(3):169-77. PubMed ID: 10029234
    [Abstract] [Full Text] [Related]

  • 7. Combined phentermine/fenfluramine administration enhances depletion of serotonin from central terminal fields.
    Lew R, Weisenberg B, Vosmer G, Seiden LS.
    Synapse; 1997 May 01; 26(1):36-45. PubMed ID: 9097403
    [Abstract] [Full Text] [Related]

  • 8. High-dose fenfluramine administration decreases serotonin transporter binding, but not serotonin transporter protein levels, in rat forebrain.
    Rothman RB, Jayanthi S, Wang X, Dersch CM, Cadet JL, Prisinzano T, Rice KC, Baumann MH.
    Synapse; 2003 Dec 01; 50(3):233-9. PubMed ID: 14515341
    [Abstract] [Full Text] [Related]

  • 9. Substituted amphetamines that produce long-term serotonin depletion in rat brain ("neurotoxicity") do not decrease serotonin transporter protein expression.
    Rothman RB, Jayanthi S, Cadet JL, Wang X, Dersch CM, Baumann MH.
    Ann N Y Acad Sci; 2004 Oct 01; 1025():151-61. PubMed ID: 15542713
    [Abstract] [Full Text] [Related]

  • 10. Interaction of phentermine plus fenfluramine: neurochemical and neurotoxic effects.
    Halladay AK, Fisher H, Wagner GC.
    Neurotoxicology; 1998 Apr 01; 19(2):177-83. PubMed ID: 9553954
    [Abstract] [Full Text] [Related]

  • 11. Administration of fenfluramine at different ambient temperatures produces different core temperature and 5-HT neurotoxicity profiles.
    Malberg JE, Seiden LS.
    Brain Res; 1997 Aug 08; 765(1):101-7. PubMed ID: 9310399
    [Abstract] [Full Text] [Related]

  • 12. 3,4-methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein.
    Wang X, Baumann MH, Xu H, Rothman RB.
    Synapse; 2004 Sep 15; 53(4):240-8. PubMed ID: 15266556
    [Abstract] [Full Text] [Related]

  • 13. Effects of repeated fenfluramine administration on indices of monoamine function in rat brain: pharmacokinetic, dose response, regional specificity and time course data.
    Zaczek R, Battaglia G, Culp S, Appel NM, Contrera JF, De Souza EB.
    J Pharmacol Exp Ther; 1990 Apr 15; 253(1):104-12. PubMed ID: 2329498
    [Abstract] [Full Text] [Related]

  • 14. Effects of fenfluramine combined with electroacupuncture on monoamine release in periaqueductal gray of rat brain.
    Li XY, Zhu CB, Chen HN, Zhu YH, Wu GC, Xu SF.
    Zhongguo Yao Li Xue Bao; 1999 Jul 15; 20(7):597-600. PubMed ID: 10678120
    [Abstract] [Full Text] [Related]

  • 15. Effect of depletion of brain serotonin by repeated fenfluramine on neurochemical and anorectic effects of acute fenfluramine.
    Kleven MS, Schuster CR, Seiden LS.
    J Pharmacol Exp Ther; 1988 Sep 15; 246(3):822-8. PubMed ID: 2458447
    [Abstract] [Full Text] [Related]

  • 16. Hyperthermia-enhanced serotonin (5-HT) depletion resulting from D-fenfluramine (D-Fen) exposure does not evoke a glial-cell response in the central nervous system of rats.
    Stewart CW, Slikker W.
    Brain Res; 1999 Aug 28; 839(2):279-82. PubMed ID: 10519050
    [Abstract] [Full Text] [Related]

  • 17. Involvement of the brain serotonergic system in the locomotor stimulant effects of chlorpheniramine in Wistar rats: implication of postsynaptic 5-HT1A receptors.
    Karamanakos PN, Pappas P, Marselos M.
    Behav Brain Res; 2004 Jan 05; 148(1-2):199-208. PubMed ID: 14684260
    [Abstract] [Full Text] [Related]

  • 18. Hyperthermia-enhanced serotonin (5-HT) depletion resulting from d-fenfluramine exposure is preventable.
    Stewart CW, Slikker W.
    Life Sci; 1999 Jan 05; 65(15):1531-6. PubMed ID: 10574218
    [Abstract] [Full Text] [Related]

  • 19. Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA ("Ecstasy") and MDA ("Love").
    McNamara R, Kerans A, O'Neill B, Harkin A.
    Neuropharmacology; 2006 Jan 05; 50(1):69-80. PubMed ID: 16188283
    [Abstract] [Full Text] [Related]

  • 20. Effects of d- and dl-chlorpheniramine on serotonin and 5-hydroxyindoleacetic acid levels in the regional parts of rat brain.
    Sakurai E, Yamasaki S, Hikichi N, Onodera K.
    Yakubutsu Seishin Kodo; 1991 Aug 05; 11(4):237-44. PubMed ID: 1724716
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.